Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kertas Basuki Rachmat Indonesia Tbk. (KBRI) vs Merck Tbk. (MERK) Price & Performance

Kertas Basuki Rachmat Indonesia Tbk.Trade
Merck Tbk.Trade

Price performance (Past 24H)

Key statistics

Kertas Basuki Rachmat Indonesia Tbk. vs Merck Tbk. — how do they compare? Kertas Basuki Rachmat Indonesia Tbk. trades at Rp50 (market cap 434.4B), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 4.1× Kertas Basuki Rachmat Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

KBRIMERK
Market Cap
434.4B1.76T
Volume
63K
Lot
630
Turnover
243.97M
Average Price
3,872.46
Value
243.97M
Indicative Equilibrium Price
3,900
Indicative Equilibrium Volume
1

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MERK
View details

About Kertas Basuki Rachmat Indonesia Tbk.

PT Kertas Basuki Rachmat Indonesia (the company) was established under its original name of PT Petroneks base on notarial deed No.21 of Mrs E Sianipar, S.H, dated on Apr 4, 1979. The Company’s articles of association has been amended several times, most recently by notarial deed No. 22 of Sutjipto, S.H., dated Feb 5, 2008, concerning among others, the change in the Company’s name.

Read more on KBRI

About Merck Tbk.

PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.

Read more on MERK